Quality of Life in the Trastuzumab for Gastric Cancer Trial

BACKGROUND. The Trastuzumab for Gastric Cancer phase III trial demonstrated that combining trastuzumab with chemotherapy significantly improved overall survival compared with chemotherapy alone in HER2-positive advanced gastric or gastroesophageal junction cancer. We report health-related quality of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Satoh, Taroh, Bang, Yung-Jue, Gotovkin, Evgeny A., Hamamoto, Yasuo, Kang, Yoon-Koo, Moiseyenko, Vladimir M., Ohtsu, Atsushi, Van Cutsem, Eric, Al-Sakaff, Nedal, Urspruch, Alexa, Hill, Julie, Weber, Harald A., Chung, Hyun-Cheol
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2014
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077451/
https://ncbi.nlm.nih.gov/pubmed/24951609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0058
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak